Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Post by Acura001on Dec 22, 2020 1:24pm
88 Views
Post# 32161774

IONC excellent revenue small cap at 3 cents

IONC excellent revenue small cap at 3 cents

IONIC Brands Announces Reinstatement of Trading by Canadian Securities Exchange and Reports Annual 2019 Revenues U.S. $10.2m and Gross Profit U.S. $1.8m, 464% Revenue Increase from 2018 with 690,038 Units Sold in 2019

TACOMA, WA / ACCESSWIRE / December 22, 2020, / IONIC BRANDS CORP. (CSE:IONC)(OTC PINK:IONKF)(FRA:1B3) ("IONIC BRANDS" or the "Company"), a regional manufacturer of innovative cannabis edibles and concentrate extract products, is pleased to announce that it was reinstated for trading by the Canadian Securities Exchange (CSE) on December 14, 2020. The Company is also pleased to provide a summary of financial results for the year ended December 31, 2019 and the nine months ended September 30, 2020.

IONIC BRANDS ANNOUNCES FIRST EBITDA POSITIVE MONTH IN JUNE 2020

IONIC BRANDS ANNOUNCES FIRST EBITDA POSITIVE QUARTER IN Q3 2020

IONIC BRANDS IMPLEMENTS STATE-OF-THE-ART CANNABIS ERP/MRP TIGUNIA HERB COMMERCE

YEAR ENDED DECEMBER 31, 2019 OVERALL PERFORMANCE

During the year ended December 31, 2019, the Company's focus was to increase its sales and reduce its operating expenses. For the year ended December 31, 2019, total revenues were $10,287,447, representing an increase of 464% compared to total revenues of $1,822,682 in the prior year. The increase in revenues was primarily due to the Company's effort in introducing new products and expansion initiatives in the states of Nevada, Oregon, and California.

Summary of 2019 & 2020 Quarterly Results 

The following table sets forth selected financial information for the Company for the following quarters. Such information is derived from unaudited financial statements and audited annual financial statements prepared by management in accordance with IFRS. All figures are presented in US dollars, except per share amounts.

 
<< Previous
Bullboard Posts
Next >>